MedPath

A multicentre clinical study of the SWIRLGRAFT ePTFE vascular access graft.

Completed
Conditions
Patients with chronic renal failure who require a prosthetic vascular access for haemodialysis.
Registration Number
NL-OMON24364
Lead Sponsor
Veryan Medical LtdMr PL BirchChief Executive Officer21 Wilson StreetLondon EC2M 2TD, UKTel. +44 1428 683 351philip.birch@veryanmed.com
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
25
Inclusion Criteria

1. Patients with chronic renal failure who require prosthetic vascular access for haemodialysis;

2. Informed consent and willing to co-operate;

Exclusion Criteria

1. Inability to comply with the study follow-up;

2. Known sensitivity to ePTFE;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Patency rates.
Secondary Outcome Measures
NameTimeMethod
1. Adverse events;<br /><br>2. Clinical experiences.
© Copyright 2025. All Rights Reserved by MedPath